Showing results (561-570 of 2,326) with videos related to
Sort By:
Pageof 233
Blood|May 15, 1995
In vitro and in vivo activity of topotecan against human B-lineage acute lymphoblastic leukemia cellsF M Uckun, C F Stewart, G Reaman, et al.Genomics|September 5, 2022
Genome-wide DNA methylation profiling of stomach cancer in the ethnic population of Mizoram, North East IndiaF A Lamare, S Khongsti, L Marthong, et al.Blood|June 1, 1993
Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiencyF M Uckun, J R Downing, R Gunther, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996
Treatment of human B-cell precursor leukemia in SCID mice using a combination of the investigational biotherapeutic agent B43-PAP with cytosine arabinosideY Messinger, Y Yanishevski, V I Avramis, et al.Leukemia & Lymphoma|December 24, 1997
Large scale manufacturing of TXU(anti-CD7)-pokeweed antiviral protein (PAP) immunoconjugate for clinical trialsD E Myers, X Jun, D Clementson, et al.Blood|August 1, 1991
Engagement of interleukin-7 receptor stimulates tyrosine phosphorylation, phosphoinositide turnover, and clonal proliferation of human T-lineage acute lymphoblastic leukemia cellsI Dibirdik, M C Langlie, J A Ledbetter, et al.Science (New York, N.Y.)|February 10, 1995
Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinasesF M Uckun, W E Evans, C J Forsyth, et al.The Journal of Biological Chemistry|March 15, 1996
Physical and functional interactions between Lyn and p34cdc2 kinases in irradiated human B-cell precursorsF M Uckun, L Tuel-Ahlgren, K G Waddick, et al.Leukemia & Lymphoma|April 1, 1997
Granulocyte-macrophage colony-stimulating factor receptor-targeted therapy of chemotherapy- and radiation-resistant human myeloid leukemiasJ P Perentesis, A E Bendel, Y Shao, et al.Leukemia & Lymphoma|August 26, 1998
In vivo toxicity and pharmacokinetic features of B43(Anti-CD19)-Genistein immunoconjugateO Ek, Y Yanishevski, T Zeren, et al.Pageof 233